Many m6A readers have been proven to be associated with distant metastasis of breast cancer and are considered promising prognostic biomarkers and therapeutic targets for breast cancer, here IGF2BP1 and YTHDF3 are examples [138–140]. Here, IGF2BP1 is linked to breast carcinoma.